Nestle (NSRGY) shares fell to a two-year low on Friday as investors considered the potential impact of Novo Nordisk’s (NVO) weight-loss drug Wegovy and how it could lead to a decrease in spending on food, Reuters’ Andrey Sychev and John Revill reports. Peers Danone (DANOY) and Unilever (UL) are also lower in New York near midday.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on NSRGY: